NASDAQ:SABS | PE Ratio | SAB Biotherapeutics, Inc.

Historical market capitalization divided by trailing-four-quarter filed net income.

Available history
2025-09-30 to 2025-12-31
Data captured

Historical PE Ratio

DatePE Ratio
2025-12-3113.41
2025-09-305.09

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.